Literature DB >> 23171115

Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia.

Francesco Violi, Pasquale Pignatelli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23171115     DOI： 10.1056/NEJMc1211471

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

1.  Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study.

Authors:  S Basili; V Raparelli; L Napoleone; G Talerico; G R Corazza; F Perticone; D Sacerdoti; A Andriulli; A Licata; A Pietrangelo; A Picardi; G Raimondo; F Violi
Journal:  Am J Gastroenterol       Date:  2017-12-19       Impact factor: 10.864

2.  Concepts and Controversies in Haemostasis and Thrombosis Associated with Liver Disease: Proceedings of the 7th International Coagulation in Liver Disease Conference.

Authors:  N M Intagliata; C K Argo; J G Stine; T Lisman; S H Caldwell; F Violi
Journal:  Thromb Haemost       Date:  2018-07-30       Impact factor: 5.249

3.  Usefulness of short-term eltrombopag treatment as a supportive treatment in hepatocellular carcinoma patients with cirrhosis and severe thrombocytopenia: A report of two cases.

Authors:  Takumi Kawaguchi; Masahito Nakano; Manabu Satani; Shuji Sumie; Shingo Yamada; Keisuke Amano; Ryoko Kuromatsu; Michio Sata
Journal:  Oncol Lett       Date:  2014-03-14       Impact factor: 2.967
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.